Use of Telemedicine in Adults with Type 1 Diabetes: Do Age and Use of Diabetes-Related Technology Matter?
Telemedicine and e-Health · 2023
DOI: 10.1089/tmj.2022.0397 ↗Kurz gefasst
Fachartikel in der Zeitschrift Telemedicine and e-Health, 2023. Verfasst von Elena Toschi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Joslin Diabetes Center, Clinical Research, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, COVID-19, Telemedicine. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
Older adults are generally less proficient in technology use compared with younger adults. Data on telemedicine use during the COVID-19 pandemic in older persons with type 1 diabetes (T1D) and the association of telemedicine with the use of diabetes-related technology are limited. We evaluated care delivery to older adults compared with younger adults with T1D in a prepandemic and pandemic period.
Methods
Data from electronic health records were evaluated for visit types (in-person, phone, and video) from two sequential 12-month intervals: prepandemic (April 2019–March 2020) and pandemic (April 2020–March 2021).
Results
Data from 2,832 unique adults with T1D were evaluated in two age cohorts: younger (40–64 years) and older (≥65 years). Half of each group used continuous glucose monitoring (CGM), whereas 54% of the younger and 37% of the older cohort used pump therapy ( p < 0.001). During the pandemic compared with the prepandemic period, visit frequency increased in both the younger (0.65 vs. 0.76 visits/patient/quarter; p < 0.01) and older (0.72 vs. 0.80 visits/patient/quarter; p < 0.01) cohorts. During the pandemic, older adults used more phone visits compared with younger adults (48% vs. 32%; p = 0.001). Patients using either pump therapy or CGM were more likely to use video visits compared with phone visits in both younger (41% vs. 24%; p < 0.001) and older cohorts (53% vs. 42%; p < 0.001).
Conclusions
Adults using diabetes-related technologies, independent of age, accessed more video visits than those not using devices. Telemedicine visits appeared to maintain continuity of care for younger and older adults with T1D, supporting the future of a hybrid-care model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Joslin Diabetes Center, Clinical Research, Boston, Massachusetts, USA.
- Beth Israel Deaconess Medical Center, Department of Medicine, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
- Boston Children's Hospital, Boston, Massachusetts, USA.
Zitieren
APA
Toschi, E., Adam, A., Atakov-Castillo, A., Slyne, C., Laffel, L., & Munshi, M. (2023). Use of Telemedicine in Adults with Type 1 Diabetes: Do Age and Use of Diabetes-Related Technology Matter?. Telemedicine and e-Health. https://doi.org/10.1089/tmj.2022.0397
Vancouver
Toschi E, Adam A, Atakov-Castillo A, Slyne C, Laffel L, Munshi M. Use of Telemedicine in Adults with Type 1 Diabetes: Do Age and Use of Diabetes-Related Technology Matter?. Telemedicine and e-Health. 2023. doi:10.1089/tmj.2022.0397
BibTeX
@article{Toschi2023,
author = {Toschi, Elena and Adam, Atif and Atakov-Castillo, Astrid and Slyne, Christine and Laffel, Lori and Munshi, Medha},
title = {Use of Telemedicine in Adults with Type 1 Diabetes: Do Age and Use of Diabetes-Related Technology Matter?},
journal = {Telemedicine and e-Health},
year = {2023},
doi = {10.1089/tmj.2022.0397}
}
EUVIMED